,Geneva College NURS 251 Module 9 (pdf) | 2026/2027 | Portage
Learning Q&A | Pharmacology
1. The nurse is reviewing the electronic health record of a client with
relapsing-remitting multiple sclerosis. An entry notes that the client is taking
interferon beta-1a (Avonex). What is the primary therapeutic purpose of this
specialty medication?
A) Suppressing the overall function of the client's immune system to prevent
organ rejection
B) Reducing the frequency of exacerbations by modulating the immune
response
C) Replacing a missing enzyme that is required for myelin production
D) Directly promoting the regrowth of damaged myelin sheaths
Correct Answer: Reducing the frequency of exacerbations by modulating the
immune response
Rationale: Interferon beta-1a (Avonex) is an immunomodulating drug used in
relapsing forms of multiple sclerosis. It reduces the number of clinical
exacerbations by modifying the immune response, not by directly replacing
enzymes or promoting nerve repair.
2. Which statement accurately describes the general role of specialty
medications in the current healthcare system?
A) They are the smallest and fastest-shrinking segment of the
pharmaceutical industry.
B) They are uniformly low in cost and available at all retail pharmacies.
C) They are high-cost drugs that are used to treat complex disease states.
D) They are exclusively available in oral tablet form without a prescription.
Correct Answer: They are high-cost drugs that are used to treat complex
disease states.
,Rationale: Specialty medications are defined as high-cost medications used
for treating complex disease states. They are challenging to manufacture
and administer and are the fastest-growing segment of the pharmaceutical
industry.
3. A patient with rheumatoid arthritis is prescribed adalimumab (Humira), a
biologic disease-modifying antirheumatic drug (bDMARD). The nurse
understands that this medication belongs to which class of specialty agents?
A) Anti-TNF monoclonal antibody
B) Interleukin-1 receptor antagonist
C) Selective co-stimulation modulator
D) Antimetabolite
Correct Answer: Anti-TNF monoclonal antibody
Rationale: Adalimumab (Humira) is an anti-TNF monoclonal antibody that
inhibits tumor necrosis factor, a key inflammatory cytokine in the
pathogenesis of rheumatoid arthritis. It is considered a biologic specialty
medication.
4. A nurse is teaching a patient who is newly diagnosed with chronic
hepatitis C about treatment with ledipasvir/sofosbuvir (Harvoni). Which
instruction is most important to include?
A) “A cure is now possible for many forms of hepatitis C, and you can expect
close monitoring while taking this medication.”
B) “This medication is a form of immunotherapy that will suppress your bone
marrow.”
C) “You will need to have this medication administered intravenously in a
hospital setting.”
, D) “A liver transplant will still be required regardless of how well this
medication works.”
Correct Answer: “A cure is now possible for many forms of hepatitis C, and
you can expect close monitoring while taking this medication.”
Rationale: Direct-acting antivirals such as ledipasvir/sofosbuvir (Harvoni)
have revolutionized hepatitis C treatment, making a cure achievable for
many patients. The medication is taken orally, but close monitoring is still
required.
5. Which of the following is a characteristic that is NOT consistent with a
specialty medication?
A) Treats a complex disease state
B) Requires only a simple once-daily tablet with no monitoring
C) Often involves a case manager to monitor the patient
D) Biologically derived and available in injection or infusion form
Correct Answer: Requires only a simple once-daily tablet with no monitoring
Rationale: Specialty medications typically require complex treatment
regimens, ongoing patient monitoring, and patient education. They are not
simple once-daily tablets without monitoring, even if an oral form exists for
some.
6. A specialty pharmacy is contracted to manage the care of a patient
receiving a biologic agent for Crohn’s disease. What is a key service that the
specialty pharmacy is expected to provide?
A) Filling the prescription at a local retail pharmacy within 30 minutes
B) Coordinating care, facilitating drug access, and providing case
management
Learning Q&A | Pharmacology
1. The nurse is reviewing the electronic health record of a client with
relapsing-remitting multiple sclerosis. An entry notes that the client is taking
interferon beta-1a (Avonex). What is the primary therapeutic purpose of this
specialty medication?
A) Suppressing the overall function of the client's immune system to prevent
organ rejection
B) Reducing the frequency of exacerbations by modulating the immune
response
C) Replacing a missing enzyme that is required for myelin production
D) Directly promoting the regrowth of damaged myelin sheaths
Correct Answer: Reducing the frequency of exacerbations by modulating the
immune response
Rationale: Interferon beta-1a (Avonex) is an immunomodulating drug used in
relapsing forms of multiple sclerosis. It reduces the number of clinical
exacerbations by modifying the immune response, not by directly replacing
enzymes or promoting nerve repair.
2. Which statement accurately describes the general role of specialty
medications in the current healthcare system?
A) They are the smallest and fastest-shrinking segment of the
pharmaceutical industry.
B) They are uniformly low in cost and available at all retail pharmacies.
C) They are high-cost drugs that are used to treat complex disease states.
D) They are exclusively available in oral tablet form without a prescription.
Correct Answer: They are high-cost drugs that are used to treat complex
disease states.
,Rationale: Specialty medications are defined as high-cost medications used
for treating complex disease states. They are challenging to manufacture
and administer and are the fastest-growing segment of the pharmaceutical
industry.
3. A patient with rheumatoid arthritis is prescribed adalimumab (Humira), a
biologic disease-modifying antirheumatic drug (bDMARD). The nurse
understands that this medication belongs to which class of specialty agents?
A) Anti-TNF monoclonal antibody
B) Interleukin-1 receptor antagonist
C) Selective co-stimulation modulator
D) Antimetabolite
Correct Answer: Anti-TNF monoclonal antibody
Rationale: Adalimumab (Humira) is an anti-TNF monoclonal antibody that
inhibits tumor necrosis factor, a key inflammatory cytokine in the
pathogenesis of rheumatoid arthritis. It is considered a biologic specialty
medication.
4. A nurse is teaching a patient who is newly diagnosed with chronic
hepatitis C about treatment with ledipasvir/sofosbuvir (Harvoni). Which
instruction is most important to include?
A) “A cure is now possible for many forms of hepatitis C, and you can expect
close monitoring while taking this medication.”
B) “This medication is a form of immunotherapy that will suppress your bone
marrow.”
C) “You will need to have this medication administered intravenously in a
hospital setting.”
, D) “A liver transplant will still be required regardless of how well this
medication works.”
Correct Answer: “A cure is now possible for many forms of hepatitis C, and
you can expect close monitoring while taking this medication.”
Rationale: Direct-acting antivirals such as ledipasvir/sofosbuvir (Harvoni)
have revolutionized hepatitis C treatment, making a cure achievable for
many patients. The medication is taken orally, but close monitoring is still
required.
5. Which of the following is a characteristic that is NOT consistent with a
specialty medication?
A) Treats a complex disease state
B) Requires only a simple once-daily tablet with no monitoring
C) Often involves a case manager to monitor the patient
D) Biologically derived and available in injection or infusion form
Correct Answer: Requires only a simple once-daily tablet with no monitoring
Rationale: Specialty medications typically require complex treatment
regimens, ongoing patient monitoring, and patient education. They are not
simple once-daily tablets without monitoring, even if an oral form exists for
some.
6. A specialty pharmacy is contracted to manage the care of a patient
receiving a biologic agent for Crohn’s disease. What is a key service that the
specialty pharmacy is expected to provide?
A) Filling the prescription at a local retail pharmacy within 30 minutes
B) Coordinating care, facilitating drug access, and providing case
management
